MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/13/2026, 06:34 PM (Berlin time), refresh in progress.

Lifeward Stock

Lifeward Ltd.

LFWDNASDAQMarkt
US$6.00
-1.0% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
Israel
CEO
Joshua Hexter
Employees
81
Market cap
$10 M
IPO
12/09/2014

Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk,…

Lifeward stock: price history

16/10/25-29.6 %16/10/26

1D

-1.0%

1W

-7.6%

1M

-13.2%

6M

-11.6%

YTD

-13.3%

1Y

-29.6%

2Y

-81.2%

5Y

-94.7%

10Y

-99.9%

Next earnings date

Next earnings date

13/11/2026 (in 27 days)

Volatility around earnings

~11% weaker price swings than usual

Ask the agents about Lifeward

Analyst assessment of Lifeward

PRICE TARGET LOW

US$10.00

CONSENSUS

US$10.00

MEDIAN

US$10.00

PRICE TARGET HIGH

US$10.00

0

STRONG BUY

4

BUY

0

HOLD

1

SELL

0

STRONG SELL

5

TOTAL · Buy

As of: 19/03/2026

ANALYST FIRMRATINGACTIONDATE
HC Wainwright & Co.Buymaintain19/03/2026
HC Wainwright & Co.Buymaintain18/11/2025
HC Wainwright & Co.Buymaintain11/03/2025 (older than 12 months)
Lake StreetBuymaintain11/03/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain20/02/2025 (older than 12 months)
Lake StreetBuymaintain20/02/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain13/11/2024 (older than 12 months)
HC Wainwright & Co.Buymaintain16/08/2024 (older than 12 months)

Lifeward stock metrics

P/E

-0.36

P/B

1.37

EV/EBITDA

-0.46

RETURN ON EQUITY

-94.3%

NET MARGIN

-173.9%

DEBT/EQUITY

0.91

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

96.7%

FLOAT SHARES

1,558,385

AVG. DAILY VOLUME (30D)

5,664

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Zamir Haggai

DirectorGrant6,711–Spontaneous10/09/2026

Greenwald Yonason

DirectorGrant6,711–Spontaneous28/08/2026

Gabay Avraham

DirectorGrant13,643–Spontaneous24/08/2026

Rose Keith Dale

OfficerGrant15,000–Spontaneous20/05/2026

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
CITADEL ADVISORS LLC18,064+18,06430/06/2026
RENAISSANCE TECHNOLOGIES LLC11,327-10030/06/2026
UBS Group AG2,152+2730/06/2026
MORGAN STANLEY274+6630/06/2026
SBI Securities Co., Ltd.196+030/06/2026
Page 1 / 3

Dividends & Stock splits

DATERATIO
24/02/20261:12
15/03/20241:7
01/04/20191:25

Comparable stocks

Frequently asked questions about Lifeward stock

What does Lifeward do?

Lifeward Ltd. is a company in the Healthcare sector, Medical - Devices industry, headquartered in Israel.

The CEO is Joshua Hexter, the company employs around 81 people.

The IPO was on 12/09/2014; the stock trades on NASDAQ under the ticker LFWD.

What do analysts say about Lifeward stock?

5 analysts rate the stock, the consensus is Buy (as of 19/03/2026).

The average price target is US$10.00, ranging from US$10.00 to US$10.00, with a median of US$10.00.

This is an external assessment, not a statement by Market Jury.

When does Lifeward report next?

The next earnings date is 13/11/2026.

Around past earnings, price swings were roughly -11% stronger than usual.

Does Lifeward pay a dividend?

No, Lifeward currently does not pay a dividend.

Which stocks are comparable to Lifeward?

Comparable stocks include Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, DexCom and GE HealthCare Technologies.

How can I get Lifeward stock analyzed?

Clicking "Analyze stock" lets five strategies assess Lifeward against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.